Skip to main content

ADVERTISEMENT

Konstantinos Katsanos, MSc, MD, PhD

FDA Panel
07/31/2019
There seems to be some sort of heterogeneity between the mortality risk and the baseline patient characteristics. We need to be able to explore this more thoroughly before we make any decisions about how to continue using paclitaxel. We need...
There seems to be some sort of heterogeneity between the mortality risk and the baseline patient characteristics. We need to be able to explore this more thoroughly before we make any decisions about how to continue using paclitaxel. We need...
There seems to be some sort of...
07/31/2019
Cath Lab Digest
FDA Panel
06/27/2019
VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.
VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.
VDM talks with Konstantinos...
06/27/2019
Vascular Disease Management